Episode 5 - CE 1 - Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction
Season 1 | Episode 5
22m | Jan 25, 2022Drs. Vicky Belousova, Alyssa Wozniak, and Gurjot Sandhu discuss the newly published Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF) trial, otherwise known as the Emperor Preserved Trial.
By listening to this episode, pharmacists in all practice settings may be eligible to receive 0.5 contact hours (0.05 CEU) of continuing education credit.
Fees: non-PAWNY members: $15.00, PAWNY members: $10.00
Sign up here:
Connect with us
- Email: pawnycast@gmail.com with your feedback and ideas for the podcast
- Social Media: check us out on Facebook and Instagram
- Website: pawnyrx.org
- Subscribe to our podcast to never miss a new episode and leave a review
- Be sure to like and review us on your favorite podcasting app!
![Audio Player Image](https://media.redcircle.com/images/2021/9/12/18/35ca8885-5f0a-4878-95bb-7762a508299e_b647_7267c392-8214-4c39-b590-7def7176320c_blob.jpg)
PAWNYCast
Loading...